It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
ANX005 in Guillain-Barré syndrome (GBS): First-in-kind monoclonal antibody designed to block C1q and the entire classical complement pathway in both the body and the brain has the potential to be the ...